| Topic Name: |
choice of sector coverage |
| Message Name: |
sectors |
| Date Posted: |
01/31/2002 |
| In Reply To: |
I have recently accepted a job with a growth-oriented buy side shop in New York. I have been given the opportunity to express a preference for sector coverage, and am having a hard time deciding what to ask for.
I don't have any particular credentials that qualify me for one over another. I will say that for whatever preconceived reason, I don't find myself particularly interested in health care, nor in retail. Other than that I'm pretty indifferent.
My guess is that it would probably be better for me in terms of professional development to develop expertise in a specific industry rather than being a generalist that covers consumer services, restaurants, etc.
In which sectors are there most consistently a demand for expertise? If I decide to leave the firm in a few years, I want to be able to market my particular focus, rather than having been a generalist.
I guess technology is kind of an obvious first pick. Tech companies are interesting to me, and that seems to match the firm's stated focus on growth companies.
Are there are other "hot" sectors? I guess biotech is another one, but I think that's bundled with health care, and I have to say I've never been particularly interested in old-economy drug companies. I guess I'm willing to consider requesting it anyway, since it's clearly a hot sector and there will probably be a lot of movement in the next few years?
What about other sectors? Among my other choices are financials, retail, media, industrials, consumer staples.
Thanks for any help or advice, especially from anyone who is an analyst on the buy side and wishes they had some other coverage area.
|
| Message: |
I'd go with tech, there is generally more growth in these companies and is becoming more and more value oriented, which means, more people will be overweighting these and will become a larger portion of the portfolios, which equates to a bigger bonus check at the end of the year. Biotech is a lot more of a science, because these companies trade on whats in the pipeline and not so much on multiples unless the product is out in the market then you have to monitor the sales. And if you are thinking about a cyclical industry for the recovery most of the players are already in, so won't be too much upside, so smaller bonus check. As for Utils good luck to you if you can figure out what portion is marked to market.
|
|
